Ahead of Kimberly-Clark (KMB) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

In its upcoming report, Kimberly-Clark (KMB) is predicted by Wall Street analysts to post quarterly earnings of $1.50 per share, reflecting a decline of 0.7% compared to the same period last year. Revenues are forecasted to be $4.84 billion, representing a year-over-year decrease of 2.6%.Over the last 30 days, there has been a downward revision of 0.3% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.With that in mind, let's delve into the average projections of some Kimberly-Clark metrics that are commonly tracked and projected by analysts on Wall Street.It is projected by analysts that the 'Net Sales- Personal Care' will reach $2.59 billion. The estimate indicates a change of -0.7% from the prior-year quarter.The collective assessment of analysts points to an estimated 'Net Sales- K-C Professional' of $738.73 million. The estimate points to a change of -9.5% from the year-ago quarter.The combined assessment of analysts suggests that 'Net Sales- Corporate & Other' will likely reach $11.67 million. The estimate suggests a change of -2.8% year over year.According to the collective judgment of analysts, 'Net Sales- Consumer Tissue' should come in at $1.52 billion. The estimate indicates a year-over-year change of -1.3%.The consensus estimate for 'Geographic Revenue- Outside North America' stands at $2.19 billion. The estimate suggests a change of -3.3% year over year.Analysts forecast 'Geographic Revenue- North America' to reach $2.71 billion. The estimate points to a change of -2.1% from the year-ago quarter.The average prediction of analysts places 'Personal Care - Net price impact - YoY change' at 2.0%. The estimate compares to the year-ago value of 4%.Based on the collective assessment of analysts, 'Total Organic Sales Growth - YoY change' should arrive at 2.0%. Compared to the present estimate, the company reported 3% in the same quarter last year.Analysts predict that the 'Personal Care - Organic Sales Growth - YoY change' will reach 4.0%. The estimate compares to the year-ago value of 6%.Analysts expect 'Operating Profit- Personal Care' to come in at $464.63 million. Compared to the current estimate, the company reported $429 million in the same quarter of the previous year.The consensus among analysts is that 'Operating Profit- K-C Professional' will reach $150.32 million. Compared to the current estimate, the company reported $151 million in the same quarter of the previous year.Analysts' assessment points toward 'Operating Profit- Consumer Tissue' reaching $264.95 million. The estimate is in contrast to the year-ago figure of $269 million.View all Key Company Metrics for Kimberly-Clark here>>>Kimberly-Clark shares have witnessed a change of -4.6% in the past month, in contrast to the Zacks S&P 500 composite's +2.7% move. With a Zacks Rank #3 (Hold), KMB is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.1% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Kimberly-Clark Corporation (KMB): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks